Skip to main content
Equibles

Laurion Capital Management LP

Position in NUVB — Nuvation Bio Inc.

CIK 1390202 NEW YORK, NY
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$44,417,673
+$10,858,556 QoQ
Shares Held
7,820,013
-0.0% QoQ
Ownership
2.23%
of shares outstanding
% of Portfolio
3.36%
of 13F equity value
Holder Rank
#6
of 242 holders
Holding Since
Mar 2022
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Laurion Capital Management LP holds $278,142,488 across 19 Biotechnology names. NUVB ranks #3 (16.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 1,352,234 $100,714,388
2 MLYS
Mineralys Therapeutics, Inc.
 2,506,152 $67,615,980
3 NUVB
Nuvation Bio Inc.
This page 		7,820,013 $44,417,673
4 BBOT
BridgeBio Oncology Therapeutics, Inc.
 2,002,701 $15,260,581
5 PYXS
Pyxis Oncology, Inc.
 4,900,888 $14,751,672
6 IMUX
Immunic, Inc.
 610,326 $9,380,710
7 AARD
Aardvark Therapeutics, Inc.
 1,034,459 $5,958,483
8 AUTL
Autolus Therapeutics plc
 3,316,626 $5,306,601

All Filings in NUVB

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $44,417,673 7,820,013
2026-03-31 $33,559,117 7,822,638
2025-12-31 $70,359,636 7,852,638
2025-09-30 $35,910,468 9,705,532
2025-06-30 $19,969,376 10,240,706
2025-03-31 $17,373,095 9,871,077
2024-12-31 $17,267,323 6,491,475
2024-09-30 $3,644,477 1,591,475
2024-06-30 $4,647,107 1,591,475
2022-06-30 $438,109 135,219
2022-03-31 $2,313,169 439,766